We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PDD icon
1101
Pinduoduo
PDD
$110B
$850K ﹤0.01%
10,901
-12,966
-54% -$1.09M
2024 Q2
9 quarters
GFL icon
1102
GFL Environmental
GFL
$18.3B
$848K ﹤0.01%
+20,265
New +$832K
2026 Q3
0 quarters
CDNS icon
1103
Cadence Design Systems
CDNS
$83.9B
$842K ﹤0.01%
+2,550
New +$838K
2026 Q3
0 quarters
SNXX icon
1104
PUT
Tradr 2X Long SNDK Daily ETF
SNXX
$450M
$834K ﹤0.01%
50,000
– –
2026 Q2
1 quarter
ALEC icon
1105
Alector
ALEC
$383M
$832K ﹤0.01%
450,000
+250,000
+125% +$483K
2026 Q2
1 quarter
NAMS icon
1106
CALL
NewAmsterdam Pharma
NAMS
$2.37B
$829K ﹤0.01%
34,100
– –
2026 Q2
1 quarter
IRE icon
1107
PUT
Defiance Daily Target 2x Long IREN ETF
IRE
$26.4M
$820K ﹤0.01%
90,000
– –
2026 Q2
1 quarter
CHRW icon
1108
C.H. Robinson
CHRW
$15.9B
$816K ﹤0.01%
5,512
– –
2024 Q3
8 quarters
CAI icon
1109
Caris Life Sciences
CAI
$5.59B
$809K ﹤0.01%
+26,400
New +$593K
2026 Q3
0 quarters
MS icon
1110
Morgan Stanley
MS
$283B
$806K ﹤0.01%
4,286
-6,228
-59% -$1.32M
2026 Q1
2 quarters
ACN icon
1111
Accenture
ACN
$134B
$801K ﹤0.01%
+4,368
New +$738K
2026 Q3
0 quarters
MKSI icon
1112
MKS
MKSI
$14.2B
$800K ﹤0.01%
3,013
+1,667
+124% +$492K
2026 Q2
1 quarter
XRPNW icon
1113
Evernorth Holdings Warrants
XRPNW
$16.9M
$798K ﹤0.01%
501,836
+216,132
+76% +$200K
2025 Q2
5 quarters
SNA icon
1114
Snap-on
SNA
$18.7B
$797K ﹤0.01%
+2,194
New +$866K
2026 Q3
0 quarters
DCH icon
1115
Dauch
DCH
$1.04B
$783K ﹤0.01%
+149,991
New +$893K
2026 Q3
0 quarters
SVIAW icon
1116
Silvia Inc Warrant
SVIAW
$4.43M
$782K ﹤0.01%
1,955,969
+112,594
+6% +$34.2K
2025 Q2
5 quarters
TROW icon
1117
T. Rowe Price
TROW
$23.4B
$782K ﹤0.01%
7,515
-13,959
-65% -$1.56M
2025 Q4
3 quarters
IEAGU icon
1118
Infinite Eagle Acquisition Corp Unit
IEAGU
$778K ﹤0.01%
75,000
– –
2026 Q1
2 quarters
HCA icon
1119
HCA Healthcare
HCA
$100B
$775K ﹤0.01%
1,817
-3,003
-62% -$1.23M
2026 Q2
1 quarter
XOM icon
1120
ExxonMobil
XOM
$655B
$775K ﹤0.01%
4,759
-4,776
-50% -$747K
2026 Q1
2 quarters
EOG icon
1121
EOG Resources
EOG
$77.6B
$766K ﹤0.01%
5,557
+2,370
+74% +$338K
2025 Q1
6 quarters
PSX icon
1122
Phillips 66
PSX
$95.5B
$761K ﹤0.01%
+2,979
New +$681K
2026 Q3
0 quarters
PEW.WS icon
1123
GrabAGun Digital Holdings Warrants
PEW.WS
$760K ﹤0.01%
2,531,666
– –
2025 Q3
4 quarters
VIR icon
1124
Vir Biotechnology
VIR
$1.57B
$758K ﹤0.01%
67,800
– –
2025 Q1
6 quarters
FSLY icon
1125
Fastly
FSLY
$2.89B
$747K ﹤0.01%
+29,100
New +$672K
2026 Q3
0 quarters

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.